1. Home
  2. NRXP vs CEV Comparison

NRXP vs CEV Comparison

Compare NRXP & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CEV
  • Stock Information
  • Founded
  • NRXP 2015
  • CEV 1999
  • Country
  • NRXP United States
  • CEV United States
  • Employees
  • NRXP N/A
  • CEV N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CEV Finance/Investors Services
  • Sector
  • NRXP Health Care
  • CEV Finance
  • Exchange
  • NRXP Nasdaq
  • CEV Nasdaq
  • Market Cap
  • NRXP 73.7M
  • CEV 70.8M
  • IPO Year
  • NRXP N/A
  • CEV N/A
  • Fundamental
  • Price
  • NRXP $2.14
  • CEV $10.45
  • Analyst Decision
  • NRXP Strong Buy
  • CEV
  • Analyst Count
  • NRXP 5
  • CEV 0
  • Target Price
  • NRXP $31.60
  • CEV N/A
  • AVG Volume (30 Days)
  • NRXP 480.7K
  • CEV 19.6K
  • Earning Date
  • NRXP 11-17-2025
  • CEV 01-01-0001
  • Dividend Yield
  • NRXP N/A
  • CEV 4.23%
  • EPS Growth
  • NRXP N/A
  • CEV N/A
  • EPS
  • NRXP N/A
  • CEV 0.36
  • Revenue
  • NRXP $242,000.00
  • CEV N/A
  • Revenue This Year
  • NRXP N/A
  • CEV N/A
  • Revenue Next Year
  • NRXP $395.09
  • CEV N/A
  • P/E Ratio
  • NRXP N/A
  • CEV $29.36
  • Revenue Growth
  • NRXP N/A
  • CEV N/A
  • 52 Week Low
  • NRXP $1.13
  • CEV $8.83
  • 52 Week High
  • NRXP $6.01
  • CEV $10.91
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 31.88
  • CEV 65.98
  • Support Level
  • NRXP $2.04
  • CEV $10.33
  • Resistance Level
  • NRXP $2.81
  • CEV $10.54
  • Average True Range (ATR)
  • NRXP 0.22
  • CEV 0.10
  • MACD
  • NRXP -0.06
  • CEV -0.00
  • Stochastic Oscillator
  • NRXP 7.41
  • CEV 82.35

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

Share on Social Networks: